Drug recalls, whether voluntary or forced by the FDA, ensure patient safety. Here are five reported by Becker's Hospital Review in the last week:
- More generic heartburn meds recalled in US.
Apotex, a drugmaker headquartered in Canada, is recalling all of its heartburn medicines containing ranitidine from the U.S., after a potentially cancer-causing impurity was found in them. - Sandoz expands recall of heartburn meds to US.
Sandoz, the generic unit of Novartis, has expanded the recall of its heartburn medications containing ranitidine to the U.S. - Torrent Pharmaceuticals expands recall of hypertension drug.
Torrent Pharmaceuticals is expanding a recall of its losartan blood pressure tablets after detecting trace amounts of a probable cancer-causing impurity. - 'It's really scary': Recall of Natpara leaves patients in limbo.
Natpara was recalled this month because tiny pieces of rubber from the injector were found in some vials of the drug, which could contaminate the drug solution. - Miami drugmaker recalls tainted sexual enhancement dietary supplement.
Fitoterapia, a Miami.-based drugmaker, is recalling 19,000 bottles of its dietary supplement for sexual enhancement due to the presence of an active ingredient Tadalafil.